Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

INSM

Insmed Inc

Jun 04 • 04:00PM ET

57.00

Dollar change +1.06
Percentage change 1.89	%

Healthcare • Biotechnology • USA • NASD

Stock Detail • Compare Perf. • Financials • Options Chain • Save to Portfolio • Create Alert

Held by: IWM VTI VB IWO IBB VXF VBK SCHA LABU VTWO

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-5.24	Insider Own	2.99%	Shs Outstand	147.98M	Perf Week	18.60%
Market Cap	8.47B	Forward P/E	-	EPS next Y	-3.94	Insider Trans	-13.85%	Shs Float	144.16M	Perf Month	123.09%
Income	-746.89M	PEG	-	EPS next Q	-1.13	Inst Own	100.61%	Short Float	6.89%	Perf Quarter	104.89%
Sales	315.49M	P/S	26.85	EPS this Y	15.64%	Inst Trans	-4.11%	Short Ratio	3.50	Perf Half Y	114.93%
Book/sh	-3.13	P/B	-	EPS next Y	12.55%	ROA	-55.80%	Short Interest	9.93M	Perf Year	191.71%
Cash/sh	4.01	P/C	14.22	EPS next 5Y	-	ROE	-1453.41%	52W Range	18.77 - 58.82	Perf YTD	83.93%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-4.82%	ROI	-111.25%	52W High	-3.09%	Beta	1.14
Dividend TTM	-	Quick Ratio	1.61	Sales past 5Y	275.45%	Gross Margin	76.46%	52W Low	203.68%	ATR (14)	3.49
Dividend Ex-Date	-	Current Ratio	1.80	EPS Y/Y TTM	-22.78%	Oper. Margin	-215.75%	RSI (14)	84.45	Volatility	8.68% 6.08%
Employees	912	Debt/Eq	-	Sales Y/Y TTM	22.54%	Profit Margin	-236.74%	Recom	1.06	Target Price	62.38
Option/Short	Yes / Yes	LT Debt/Eq	-	EPS Q/Q	9.69%	Payout	-	Rel Volume	1.26	Prev Close	55.94
Sales Surprise	-2.90%	EPS Surprise	14.36%	Sales Q/Q	15.77%	Earnings	May 09 BMO	Avg Volume	2.84M	Price	57.00
SMA20	76.51%	SMA50	98.41%	SMA200	110.98%	Trades		Volume	3,586,992	Change	1.89%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-23-24	Initiated	Truist	Buy	$48
Feb-15-24	Initiated	Wolfe Research	Outperform	$42
Dec-08-23	Initiated	Wells Fargo	Overweight	$55
Nov-20-23	Resumed	JP Morgan	Overweight	$36
Jul-26-23	Initiated	Guggenheim	Buy	$50
Dec-09-22	Initiated	Mizuho	Buy	$28
Dec-07-22	Initiated	Barclays	Overweight	$37
Nov-18-22	Initiated	BofA Securities	Buy	$39
Apr-27-22	Initiated	Goldman	Buy	$56
Dec-06-21	Initiated	JP Morgan	Overweight	$45
Oct-19-21	Resumed	Morgan Stanley	Overweight	$56 → $52
Oct-19-21	Resumed	Monness Crespi & Hardt	Buy	$52
Oct-08-21	Initiated	Cantor Fitzgerald	Overweight	$60
Apr-26-21	Resumed	Credit Suisse	Outperform	$60
Dec-17-20	Initiated	Berenberg	Buy	$48
Oct-12-20	Resumed	Stifel	Buy	$44
Sep-03-19	Initiated	Goldman	Buy	$30
Apr-09-19	Reiterated	H.C. Wainwright	Buy	$43 → $52
Feb-15-19	Upgrade	JMP Securities	Mkt Perform → Mkt Outperform	$40
Jan-17-19	Upgrade	Goldman	Neutral → Buy

Show Previous Ratings

Jun-04-24 06:00AM	The 3 Most Undervalued Biotech Stocks to Buy in June 2024 (InvestorPlace)
May-30-24 04:05PM	Insmed to Host Commercial Webinar on June 4, 2024 (PR Newswire) +6.41%
08:00AM	Insmed Announces Pricing of $650 Million Public Offering of Common Stock (PR Newswire)
May-29-24 12:20PM	Insmed (INSM) Stock Soars 118% on Upbeat Lung Disease Drug Data (Zacks) +11.42%
06:05AM	Insmed stocks soar as Phase III lung disease drug exceeds expectations (Clinical Trials Arena)
07:25PM	Loading…
May-28-24 07:25PM	Insmed CEO on lung disease treatment and path forward (CNBC TV) +118.45%
06:21PM	Insmed Announces Proposed $500 Million Public Offering of Common Stock (PR Newswire)
04:49PM	Insmed Stock More Than Doubled in Value Tuesday Here's Why (Investopedia)
04:02PM	The Next Humira? Insmed Catapults 119% On Its 'Very Attractive' Opportunity In Lung Disease. (Investor's Business Daily)
03:41PM	Insmed stock blasts off over lung condition study results (Yahoo Finance Video)
02:24PM	Chart of the Day: Insmed (CNBC TV)
02:21PM	Insmed Stock Surges on Trial Win for Lung-Condition Drug. We Hit the Mark, CEO Says. (Barrons.com)
01:16PM	Stocks to Watch Tuesday: GameStop, Apple, Nvidia, Hess (The Wall Street Journal)
12:20PM	Insmed, Agios rise; DraftKings, Atlantica fall, Tuesday, 5/28/2024 (Associated Press Finance)
10:58AM	Why Is Inflammatory Diseased-Focused Insmed Stock Soaring On Tuesday? (Benzinga)
10:01AM	Loading…
10:01AM	Insmed's shares double as lung disease med powers past expectations in phase 3 (FierceBiotech.com)
09:36AM	Insmed Shares Rocket After Drug Eases Lung Disease Symptoms (Bloomberg)
09:04AM	Insmed Catapults 128% After Proving Its Theory In A 'Large, Untapped' Lung Disease Market (Investor's Business Daily)
09:00AM	Insmed Stock More Than Doubles on Trial Win for Lung-Condition Drug (Barrons.com)
08:40AM	Why Is Insmed (INSM) Stock Up 134% Today? (InvestorPlace)
07:27AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday (InvestorPlace)
06:30AM	Insmed Announces Positive Topline Results from Landmark ASPEN Study of Brensocatib in Patients with Bronchiectasis (PR Newswire)
03:25AM	Nvidia, Apple and GameStop rise premarket; Tesla, DraftKings fall (Investing.com)
May-27-24 06:47PM	Is Insmed Incorporated (NASDAQ:INSM) a Buy According to Hedge Funds? (Insider Monkey)
06:13PM	7 Best Mid-Cap Healthcare Stocks To Buy Now (Insider Monkey)
04:00PM	Insmed to Host Investor Call to Discuss Topline Results from Phase 3 ASPEN Study of Brensocatib in Patients with Bronchiectasis (PR Newswire)
May-20-24 05:58PM	Insmed Lung Infections Treatment Study Shows Improvement (MT Newswires)
04:28PM	Insmed Presents Positive Patient-Reported Outcomes and Microbiologic Data from Phase 3 ARISE Study Of ARIKAYCE (Amikacin Liposome Inhalation Suspension) in Patients with NTM Lung Disease Caused by MAC at American Thoracic Society 2024 International Conference Plenary Session (PR Newswire)
May-17-24 07:00PM	Insider Sale: Chief Medical Officer Martina Flammer Sells Shares of Insmed Inc (INSM) (GuruFocus.com)
May-15-24 08:36AM	Goldman Sachs Adjusts Price Target on Insmed to $49 From $40, Maintains Buy Rating (MT Newswires)
03:33PM	Loading…
May-10-24 03:33PM	Insmed Incorporated (NASDAQ:INSM) Q1 2024 Earnings Call Transcript (Insider Monkey)
12:48PM	Insmed Inc (INSM) Reports Q1 2024 Earnings: Misses EPS Estimates, Revenue Grows Amidst Clinical ... (GuruFocus.com)
11:14AM	Insmed (INSM) Beats on Q1 Earnings, Posts Upbeat Pipeline Updates (Zacks)
10:36AM	Mizuho Securities Raises Price Target on Insmed to $36 From $35, Keeps Buy Rating (MT Newswires)
May-09-24 11:55AM	INSM Stock Earnings: Insmed Beats EPS, Misses Revenue for Q1 2024 (InvestorPlace)
10:00AM	Insmed (INSM) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates (Zacks)
08:15AM	Insmed (INSM) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
07:45AM	Insmed's Q1 Net Loss Narrows as Revenue Advances (MT Newswires)
07:16AM	Insmed: Q1 Earnings Snapshot (Associated Press Finance)
07:00AM	Insmed Reports First-Quarter 2024 Financial Results and Provides Business Update (PR Newswire)
May-08-24 10:19AM	Should You Buy Insmed (INSM) Ahead of Earnings? (Zacks)
May-07-24 08:00AM	Insmed To Present at the BofA Securities Health Care Conference 2024 (PR Newswire)
May-03-24 08:00AM	Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire)
May-02-24 10:01AM	Insmed (INSM) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
Apr-25-24 08:00AM	Insmed to Host First-Quarter 2024 Financial Results Conference Call on Thursday, May 9, 2024 (PR Newswire)
Apr-10-24 12:40PM	What Makes Insmed (INSM) a Lucrative Investment? (Insider Monkey)
Apr-05-24 08:00AM	Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire)
Mar-27-24 04:05PM	Insmed to Present New Data from Across its Respiratory Portfolio at the American Thoracic Society 2024 International Conference (PR Newswire)
Mar-05-24 08:00AM	Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire)
Feb-29-24 08:00AM	Insmed To Present at Three March Conferences (PR Newswire)
Feb-28-24 04:05PM	Actress Jane Seymour and Insmed Raise Awareness of 'Unseenism' and Empower People to Speak Up When It Comes to Their Health (PR Newswire)
Feb-23-24 12:23PM	Insmed Incorporated (NASDAQ:INSM) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-22-24 10:35PM	Q4 2023 Insmed Inc Earnings Call (Thomson Reuters StreetEvents)
08:10AM	Insmed (INSM) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
07:28AM	Insmed: Q4 Earnings Snapshot (Associated Press Finance)
07:00AM	Insmed Reports Fourth-Quarter and Full-Year 2023 Financial Results and Provides Business Update (PR Newswire)
Feb-15-24 10:00AM	Insmed (INSM) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
Feb-13-24 01:35PM	5 Best Strong Buy Stocks To Invest In (Insider Monkey)
Feb-08-24 08:00AM	Insmed to Host Fourth-Quarter and Full Year 2023 Financial Results Conference Call on Thursday, February 22, 2024 (PR Newswire)
Feb-02-24 04:05PM	Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire)
Jan-13-24 05:13PM	Insmed Inc Chief Medical Officer Martina Flammer Sells 4,667 Shares (GuruFocus.com)
Jan-12-24 05:02PM	Insmed Inc Chief People Strategy Officer Sells Company Shares (GuruFocus.com)
Jan-06-24 02:32AM	Insmed Inc Chief Commercial Officer John Wise Sells 21,238 Shares (GuruFocus.com)
Jan-05-24 08:00AM	Insmed Provides Business Update at 42nd Annual J.P. Morgan Healthcare Conference (PR Newswire)
Jan-04-24 08:00AM	Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire)
Jan-02-24 08:00AM	Insmed To Present at the 42nd Annual J.P. Morgan Healthcare Conference (PR Newswire)
Dec-23-23 11:01AM	Insmed Inc Chief Medical Officer Martina Flammer Sells 28,310 Shares (GuruFocus.com)
Dec-05-23 01:34PM	12 Most Promising Stocks to Buy According to Hedge Funds (Insider Monkey)
08:00AM	Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire)
Nov-29-23 08:00AM	Insmed To Present at the Nasdaq 49th Investor Conference (PR Newswire) +5.46%
Nov-14-23 03:56PM	Vanguard Group Inc Adds Shares in Insmed Inc (GuruFocus.com)
Nov-08-23 08:00AM	Insmed To Present at Two November Conferences (PR Newswire)
Nov-03-23 08:00AM	Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire)
Nov-02-23 08:00AM	Insmed Holds Second Annual Global Day of Good to Benefit Communities Across the Globe (PR Newswire)
Oct-30-23 01:53AM	The Insmed Inc (INSM) Company: A Short SWOT Analysis (GuruFocus.com)
Oct-28-23 03:19PM	Insmed Incorporated (NASDAQ:INSM) Q3 2023 Earnings Call Transcript (Insider Monkey)
Oct-26-23 04:05PM	Insmed Ranks No. 1 on Science's 2023 Top Biopharma Employers List (PR Newswire)
09:32AM	Insmed Inc (INSM) Reports Q3 2023 Earnings and Provides Business Update (GuruFocus.com)
08:50AM	Insmed (INSM) Reports Q3 Loss, Tops Revenue Estimates (Zacks)
07:41AM	Insmed: Q3 Earnings Snapshot (Associated Press Finance)
07:30AM	Insmed Reports Third-Quarter 2023 Financial Results and Provides Business Update (PR Newswire)
Oct-24-23 10:00AM	Amgen (AMGN) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release (Zacks)
08:00AM	Insmed and Google Cloud Collaborate to Transform the Lives of Patients by Harnessing the Power of AI (PR Newswire)
Oct-19-23 10:02AM	Will Insmed (INSM) Report Negative Earnings Next Week? What You Should Know (Zacks)
Oct-12-23 08:00AM	Insmed to Host Third-Quarter 2023 Financial Results Conference Call on Thursday, October 26, 2023 (PR Newswire)
Oct-06-23 08:00AM	Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire)
Sep-26-23 08:00AM	Insmed To Present at Chardan's 7th Annual Genetic Medicines Conference (PR Newswire)
Sep-08-23 02:09PM	Why Shares of Insmed Are Soaring This Week (Motley Fool)
08:00AM	Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire)
Sep-06-23 08:00AM	Insmed To Present at the Morgan Stanley 21st Annual Global Healthcare Conference (PR Newswire)
07:46AM	Insmed (INSM) Up on Positive Data From MAC Lung Disease Study (Zacks)
Sep-05-23 07:32PM	Insmed (INSM): A Hidden Gem or Just Modestly Undervalued? (GuruFocus.com) +16.48%
04:10PM	Insmed Is Making A Comeback Why Shares Hit A Year High In Record Volume (Investor's Business Daily)
12:18PM	Insmed Inc's Meteoric Rise: Unpacking the 34% Surge in Just 3 Months (GuruFocus.com)
11:52AM	Why Insmed Stock Is Soaring Today (Motley Fool)
07:00AM	INSMED ANNOUNCES POSITIVE TOPLINE RESULTS FROM PHASE 3 ARISE STUDY OF ARIKAYCE® (AMIKACIN LIPOSOME INHALATION SUSPENSION) IN PATIENTS WITH NTM LUNG DISEASE CAUSED BY MAC (PR Newswire)
Aug-04-23 08:00AM	Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (PR Newswire)
Aug-03-23 09:05AM	Insmed (INSM) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
07:55AM	Insmed: Q2 Earnings Snapshot (AP Finance)
07:30AM	Insmed Reports Second-Quarter 2023 Financial Results and Provides Business Update (PR Newswire)

Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline. The company was founded in 1988 and is headquartered in Bridgewater, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Flammer Martina M.D.	Chief Medical Officer	May 30 '24	Option Exercise	23.75	21,195	503,381	127,329	May 30 05:43 PM
Flammer Martina M.D.	Chief Medical Officer	May 30 '24	Sale	55.00	21,195	1,165,725	106,134	May 30 05:43 PM
Bonstein Sara	Chief Financial Officer	May 29 '24	Option Exercise	26.57	220,564	5,861,212	358,769	May 30 05:41 PM
Bonstein Sara	Chief Financial Officer	May 29 '24	Sale	50.00	220,564	11,028,200	117,481	May 30 05:41 PM
Flammer Martina M.D.	Chief Medical Officer	May 28 '24	Option Exercise	23.66	103,806	2,456,050	209,940	May 30 05:43 PM
Smith Michael Alexander	Chief Legal Officer	May 28 '24	Option Exercise	14.27	38,971	556,079	133,550	May 30 05:45 PM
Bonstein Sara	Chief Financial Officer	May 28 '24	Option Exercise	26.26	20,724	544,247	326,613	May 30 05:41 PM
Schaeffer Orlov S Nicole	Chief People Strategy Officer	May 28 '24	Option Exercise	12.58	27,500	345,950	136,260	May 30 05:44 PM
Wise John Drayton	Chief Commercial Officer	May 28 '24	Option Exercise	12.58	6,250	78,625	127,907	May 30 05:46 PM
Flammer Martina M.D.	Chief Medical Officer	May 28 '24	Sale	49.62	103,806	5,150,854	106,134	May 30 05:43 PM
Smith Michael Alexander	Chief Legal Officer	May 28 '24	Sale	49.53	44,722	2,215,081	88,828	May 30 05:45 PM
Schaeffer Orlov S Nicole	Chief People Strategy Officer	May 28 '24	Sale	49.53	27,500	1,362,075	108,760	May 30 05:44 PM
Bonstein Sara	Chief Financial Officer	May 28 '24	Sale	50.01	20,724	1,036,407	338,045	May 30 05:41 PM
Wise John Drayton	Chief Commercial Officer	May 28 '24	Sale	49.79	7,852	390,918	121,657	May 30 05:46 PM
Adsett Roger	Chief Operating Officer	May 17 '24	Sale	25.09	5,945	149,160	149,275	May 17 04:15 PM
Flammer Martina M.D.	Chief Medical Officer	May 17 '24	Sale	25.09	4,642	116,468	106,134	May 17 04:16 PM
Lewis William	Chair and CEO	May 14 '24	Sale	25.52	22,198	566,493	384,125	May 15 04:34 PM
Bonstein Sara	Chief Financial Officer	May 14 '24	Sale	25.32	11,088	280,748	117,481	May 15 04:32 PM
Flammer Martina M.D.	Chief Medical Officer	May 14 '24	Sale	25.47	10,640	271,001	110,776	May 15 04:33 PM
Adsett Roger	Chief Operating Officer	May 14 '24	Sale	25.50	7,857	200,354	155,220	May 15 04:31 PM
Schaeffer Orlov S Nicole	Chief People Strategy Officer	May 14 '24	Sale	25.53	6,508	166,149	108,760	May 15 04:36 PM
Wise John Drayton	Chief Commercial Officer	May 14 '24	Sale	25.47	5,088	129,591	123,259	May 15 04:39 PM
Smith Michael Alexander	Chief Legal Officer	May 14 '24	Sale	25.40	5,093	129,362	94,579	May 15 04:37 PM
Lewis William	Chair and CEO	Feb 28 '24	Option Exercise	12.58	50,000	629,000	50,500	Feb 29 04:08 PM
Adsett Roger	Chief Operating Officer	Jan 12 '24	Sale	28.63	5,251	150,336	148,559	Jan 12 04:05 PM
Flammer Martina M.D.	Chief Medical Officer	Jan 12 '24	Sale	28.63	4,667	133,616	106,898	Jan 12 04:06 PM
Adsett Roger	Chief Operating Officer	Jan 10 '24	Sale	28.90	3,536	102,190	153,810	Jan 11 04:06 PM
Flammer Martina M.D.	Chief Medical Officer	Jan 10 '24	Sale	28.90	1,245	35,980	111,565	Jan 11 04:08 PM
Schaeffer Orlov S Nicole	Chief People Strategy Officer	Jan 09 '24	Option Exercise	20.49	503	10,306	105,652	Jan 11 04:10 PM
Lewis William	Chair and CEO	Jan 09 '24	Sale	28.72	9,887	283,955	363,651	Jan 10 04:15 PM
Flammer Martina M.D.	Chief Medical Officer	Jan 09 '24	Sale	29.01	4,715	136,782	112,810	Jan 11 04:08 PM
Bonstein Sara	Chief Financial Officer	Jan 09 '24	Sale	29.18	4,497	131,222	114,051	Jan 11 04:07 PM
Adsett Roger	Chief Operating Officer	Jan 09 '24	Sale	29.25	3,837	112,232	157,346	Jan 11 04:06 PM
Schaeffer Orlov S Nicole	Chief People Strategy Officer	Jan 09 '24	Sale	28.85	3,668	105,831	101,984	Jan 11 04:10 PM
Smith Michael Alexander	General Counsel, Senior VP	Jan 09 '24	Sale	28.76	2,373	68,247	86,364	Jan 11 04:11 PM
Wise John Drayton	Chief Commercial Officer	Jan 09 '24	Sale	28.78	1,861	53,560	113,829	Jan 11 04:13 PM
Lewis William	Chair and CEO	Jan 08 '24	Option Exercise	20.49	45,120	924,509	398,489	Jan 10 04:15 PM
Lewis William	Chair and CEO	Jan 08 '24	Sale	29.45	45,120	1,328,973	373,538	Jan 10 04:15 PM
Lewis William	Chair and CEO	Jan 05 '24	Sale	29.26	6,979	204,195	373,538	Jan 05 05:29 PM
Adsett Roger	Chief Operating Officer	Jan 05 '24	Sale	29.21	3,042	88,864	161,183	Jan 05 05:26 PM
Schaeffer Orlov S Nicole	Chief People Strategy Officer	Jan 05 '24	Sale	29.28	1,457	42,661	105,149	Jan 05 05:32 PM
Flammer Martina M.D.	Chief Medical Officer	Jan 05 '24	Sale	29.20	1,386	40,478	117,525	Jan 05 05:29 PM
Wise John Drayton	Chief Commercial Officer	Jan 05 '24	Sale	29.32	1,167	34,216	115,690	Jan 05 05:33 PM
Smith Michael Alexander	General Counsel, Senior VP	Jan 05 '24	Sale	29.30	627	18,374	88,737	Jan 05 05:32 PM
Wise John Drayton	Chief Commercial Officer	Jan 03 '24	Option Exercise	19.11	20,071	383,557	124,055	Jan 05 05:33 PM
Wise John Drayton	Chief Commercial Officer	Jan 03 '24	Sale	29.19	20,071	585,872	103,984	Jan 05 05:33 PM
Schaeffer Orlov S Nicole	Chief People Strategy Officer	Dec 28 '23	Option Exercise	20.49	22,288	456,681	116,837	Jan 02 04:04 PM
Schaeffer Orlov S Nicole	Chief People Strategy Officer	Dec 28 '23	Sale	32.00	22,288	713,216	94,549	Jan 02 04:04 PM
Flammer Martina M.D.	Chief Medical Officer	Dec 22 '23	Option Exercise	23.66	28,310	669,815	134,348	Dec 22 04:04 PM
Flammer Martina M.D.	Chief Medical Officer	Dec 22 '23	Sale	30.00	28,310	849,300	106,038	Dec 22 04:04 PM
Bonstein Sara	Chief Financial Officer	Dec 22 '23	Sale	30.00	13,199	395,970	105,241	Dec 22 04:03 PM
Lewis William	Chair and CEO	Oct 27 '23	Option Exercise	14.24	112,500	1,602,000	289,274	Oct 31 04:04 PM
Lewis William	Chair and CEO	Oct 27 '23	Sale	24.08	112,000	2,696,449	0	Oct 31 04:04 PM
Smith Michael Alexander	General Counsel, Senior VP	Jul 11 '23	Sale	20.18	740	14,933	77,142	Jul 13 04:01 PM
Adsett Roger	Chief Operating Officer	Jun 13 '23	Sale	19.32	8,981	173,513	151,352	Jun 15 04:05 PM
Flammer Martina M.D.	Chief Medical Officer	Jun 13 '23	Sale	19.27	8,868	170,886	106,038	Jun 15 04:06 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

INSM

Insmed Inc

Upgrade your FINVIZ experience